This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Scientific Games Announces Consent Solicitation

NEW YORK, Oct. 19, 2011 /PRNewswire/ -- Scientific Games Corporation (Nasdaq: SGMS) (the "Company") announced today that its direct wholly owned subsidiary, Scientific Games International, Inc. ("SGI"), is soliciting consents (the "Consent Solicitation") from the holders of the 7.875% Senior Subordinated Notes due 2016 (CUSIP Nos. 80874YAA8 and ISIN USU8067TAA44) (the "Notes"), to proposed amendments to the Indenture which governs the Notes (the "Indenture").

The terms and conditions of the Consent Solicitation and the proposed amendments to the Indenture are described in the Consent Solicitation Statement dated October 19, 2011 (the "Consent Solicitation Statement").  The purpose of the Consent Solicitation is to amend the Indenture to provide the Company with additional flexibility for investment opportunities that it may decide to pursue, including potential strategic partnerships, joint ventures and other acquisitions.

The Consent Solicitation is scheduled to expire at 5:00 p.m., New York City time, on October 27, 2011 (the "Expiration Date"). SGI has established October 18, 2011 as the record date for the Consent Solicitation.  In the event that the conditions of the Consent Solicitation are satisfied or waived, including the receipt of the requisite consents as to not less than a majority of the $200 million in aggregate principal amount of the Notes at or prior to the Expiration Date and the effectiveness of a supplemental indenture implementing the proposed amendments, SGI will pay to holders of record of the Notes $25.00 per $1,000 principal amount of Notes as to which they have delivered (and not validly revoked) consents prior to the Expiration Date.

The Company has engaged Credit Suisse Securities ( USA) LLC and UBS Securities LLC as its solicitation agents (the "Solicitation Agents"). Questions and requests for assistance regarding this solicitation should be directed to Credit Suisse Securities ( USA) LLC at (212) 325-5912 (call collect) or (800) 820-1653 (toll free) or to UBS Securities LLC at (203) 719-4210 (call collect) or (888) 719-4210 (toll free). Requests for documents may be directed to Global Bondholder Services Corporation, which is acting as the information agent (the "Information Agent") and tabulation agent ("Tabulation Agent") for the Consent Solicitation, at (866) 795-2200 (toll free) or (212) 430-3774 (banks and brokers).

None of the Company, SGI or any of their subsidiaries, the Solicitation Agents, the Tabulation Agent, the Information Agent or The Bank of Nova Scotia Trust Company of New York, as trustee under the Indenture, make any recommendations as to whether or not holders of the Notes should deliver consents pursuant to the Consent Solicitation, and no one has been authorized by any of them to make such recommendations.

This press release does not constitute a solicitation of consents of holders of the Notes and shall not be deemed a solicitation of consents with respect to any other securities of the Company. The Consent Solicitation will be made solely by the Consent Solicitation Statement and the accompanying consent form.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,156.85 +24.88 0.15%
S&P 500 2,001.57 +2.59 0.13%
NASDAQ 4,562.1890 +9.43 0.21%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs